Browse Biological products industry topic

Officials and employees subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words William D. Young to Become Chairman of Biogen Idec. Dec 10, 2009 575 NovaDigm Therapeutics Appoints Vaccine Industry Leader R. Gordon Douglas, Jr., as Chairman of the Board. Dec 3, 2009 908 Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman. Dec 2, 2009 1225 AnaptysBio Inc. Pirillo, Katie Brief article Nov 23, 2009 97 Amarin Appoints John F. Thero as Chief Financial Officer. Nov 6, 2009 574 Dynavax Appoints Francis R. Cano, Ph.D. to Board of Directors. Nov 5, 2009 272 Acorda Therapeutics Reports Third Quarter 2009 Financial Results. Financial report Nov 3, 2009 1404 Telormedix Appoints Johanna Holldack as CEO. Oct 27, 2009 575 Mountain West Business Solutions Acquires Sunshine Biopharma. Oct 20, 2009 413 Gilead Sciences Announces Record Third Quarter 2009 Financial Results. Oct 20, 2009 2653 Ireland : Amarin Announces Completion of $70 Million Private Placement. Oct 20, 2009 494 Amarin Announces Completion of $70 Million Private Placement. Oct 19, 2009 889 Genentech chairman resigns from Google board. Oct 17, 2009 422 Axion Appoints Gary R. Anthony as Chief Financial Officer. Oct 16, 2009 595 Genentech chairman resigns from Google board. Oct 15, 2009 422 Genentech chairman resigns from Google board. Oct 14, 2009 422 Amarin Announces Changes to Its Board and Management Team. Oct 13, 2009 1375 Genentech chairman resigns from Google board. Oct 13, 2009 420 GTC Biotherapeutics Announces Changes in Board. Oct 5, 2009 618 Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at Enzo Clinical Labs. Sep 8, 2009 553 Calvin B. Harley to Retire as Chief Scientific Officer of Geron. Sep 8, 2009 405 Celldex Therapeutics Announces Appointment of Larry Ellberger as Chairman of the Board. Sep 4, 2009 659 Genentech, an Oceanside biotech company, has named Larry Sanders as its new vice president and general manager. Owen, Ted Aug 24, 2009 57 Sutro Biopharma Announces Additions to Board of Directors and Senior Management Team. Aug 20, 2009 573 BioTime, Inc. Appoints Pedro Lichtinger to Its Board of Directors. Aug 17, 2009 565 Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharmaceutical Operations. Aug 12, 2009 426 BioTime Appoints Walter Funk Vice President for Stem Cell Research. Aug 10, 2009 777 Acorda Therapeutics Names Ruhi Kahn as Vice President, Business Development. Aug 5, 2009 623 Kevin E. Lofton Joins Gilead Sciences' Board of Directors. Jul 29, 2009 290 Genocea Biosciences Appoints John Sorvillo Vice President of Business Development. Jul 27, 2009 412 ARCA biopharma Announces Changes to Management Team Reflecting Change in Commercial Strategy. Jul 1, 2009 643 Luminex Corporation Announces Executive Appointments. Jun 24, 2009 601 Genocea Biosciences Names Robert E. Farrell, Jr. Vice President, Finance and Administration. Jun 19, 2009 343 Digitiliti Announces New Directors, One Year Form 10 Filing. May 21, 2009 704 Titan Re-Engages Key Executives. May 20, 2009 488 Molecular Diagnostics Company, RedPath, Appoints Dennis M. Smith, Jr., M.D. as Chief Medical Officer. May 19, 2009 376 Geron Appoints Stephen Kelsey as Executive Vice President and Chief Medical Officer for Oncology, and Hassan Movahhed as Vice President of Clinical Operations for Oncology. Apr 27, 2009 653 Acorda Therapeutics Names Anthony Caggiano Vice President, Preclinical Development. Apr 10, 2009 687 Seattle Genetics Announces Management Team Addition and Promotion to Support SGN-35 Commercialization Initiatives. Apr 7, 2009 861 Xcellerex Appoints David J. Williams, Retired Chairman/CEO of Sanofi Pasteur, to its Board of Directors. Apr 1, 2009 456 Biogen Idec Names Robert Hamm Chief Operating Officer. Mar 30, 2009 478 Geron Corporation Appoints Karin Eastham to Its Board of Directors. Mar 30, 2009 360 Biogen Idec Announces Head of Research and Development Dr. Cecil B. Pickett to Retire. Mar 12, 2009 697 Neugenesis Corporation Strengthens Executive Team: Michael J. Buckley Appointed COO. Mar 10, 2009 369 Enzo Biochem Names Kevin Krenitsky President of Enzo Clinical Labs. Mar 6, 2009 569 Osteotech expanding its senior management team. Mar 1, 2009 416 ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer. Feb 25, 2009 889 Biogen Idec Names Michael Lytton Executive Vice President of Business Development. Feb 23, 2009 349 Genocea Biosciences Closes $23 Million Series A Financing, Names Vaccine Veteran Staph Leavenworth Bakali CEO. Feb 19, 2009 557 Genocea Biosciences Names Jane Halpern Vice President of Regulatory Affairs. Feb 11, 2009 445 Gilead Announces Senior Management Promotion. Feb 2, 2009 313 ARCA biopharma and Nuvelo Complete Merger Creating Late-Stage Cardiovascular Company. Jan 28, 2009 897 Geron Announces John Walker Resigns as Director. Jan 28, 2009 298 New Leaf Venture Partners Appoints Dr. Srinivas Akkaraju as Managing Director and Lead of the Firm's West Coast Biopharmaceuticals Practice. Jan 22, 2009 389 Genentech Executive Joins Federal Reserve Bank of San Francisco Economic Advisory Council. Jan 21, 2009 474 William J. Newell Named Chief Executive Officer of Sutro Biopharma. Jan 12, 2009 670 ARCA biopharma Appoints Derek Cole as Vice President, Investor Relations and Corporate Communications. Jan 12, 2009 389 Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO. Jan 5, 2009 447 Depomed Announces Management Promotions. Jan 5, 2009 590 Directors Roster: a quarterly record of new director appointments. Jan 1, 2009 10780 ORTEC Names Don Addington Executive Vice President. Dec 9, 2008 497 FibroGen Appoints Frank H. Valone, M.D., Chief Medical Officer. Dec 1, 2008 355 Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer. Nov 12, 2008 759 Amarin Appoints Dr. Lars Ekman as Non-Executive Director. Nov 3, 2008 698 BioReliance Corporation Appoints Andrew Paterson Ph.D. as Senior Director/General Manager for UK Operations. Oct 14, 2008 350 Synageva BioPharma Appoints Leading Clinician and Industry Executive, Dr. Mark Goldberg, to its Board of Directors. Oct 10, 2008 382 Seattle Genetics Adds to Senior Management Team. Sep 30, 2008 768 AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics. Sep 29, 2008 1126 United States : PDL BioPharma names CEO for spin-off company. Sep 26, 2008 228 Amarin Announces Financial Results for Second Quarter 2008. Sep 25, 2008 2229 Amarin Appoints Dr. Mehar S. Manku to Chief Scientist. Sep 23, 2008 739 Cyclacel Appoints Nicholas Bacopoulos, Ph.D. to Board of Directors. Sep 8, 2008 790 Synageva BioPharma Appoints Sanj K. Patel President and Chief Executive Officer and Opens New Corporate Headquarters. Sep 4, 2008 462 BioReliance Corporation Appoints James Kramer, Ph.D., Vice President, Global Biologics Operations. Aug 26, 2008 392 MicroIslet Appoints Seasoned Finance Industry Veteran as CFO. Aug 20, 2008 715 StemCells, Inc. Appoints Stewart Craig, Ph.D., Senior Vice President, Development and Operations. Aug 13, 2008 972 Biological E. Names Experienced Biopharmaceutical Executive, Rayasam Prasad, as Chief Operating Officer for Global Biologics. Aug 7, 2008 258 Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc. Aug 6, 2008 771 GILEAD SCIENCES REPORTS 2ND QTR REVENUES OF $1.28 BILLION. Financial report Aug 1, 2008 1855 Biogen Idec Names Brian S. Posner to Board of Directors. Jul 24, 2008 290 Gilead Sciences Announces Second Quarter 2008 Financial Results. Jul 17, 2008 2417 VLST Corporation Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer. Jul 2, 2008 515 ZOLL Medical Corporation Announces the Addition of a President. Jun 30, 2008 657 Biogen Idec Names Hans Peter Hasler Chief Operating Officer. May 29, 2008 669 Titan Pharmaceuticals, Inc. Executive Chairman, Dr. Louis R. Bucalo, Retires to Pursue Other Interests. Apr 30, 2008 386 BioReliance Names Darryl L. Goss to Lead New Toxicology/LADS Business Unit. Apr 8, 2008 614 Acorda Therapeutics Names John Librie Senior Vice President, Sales and Marketing. Apr 3, 2008 691 Cerus Appoints Carol M. Moore as Vice President, Regulatory Affairs and Quality. Mar 31, 2008 309 AVAX Appoints Chief Medical Officer for EMEA. Mar 31, 2008 1082 Array BioPharma Names Gary M. Clark, Ph.D., Vice President, Biostatistics and Data Management. Mar 18, 2008 703 AVI BioPharma Announces 2007 Fourth Quarter and Full Year Financial Results. Financial report Mar 12, 2008 1267 Gilead Appoints Dr. John J. Toole as Senior Vice President, Corporate Development. Mar 6, 2008 266 Cerus Promotes Laurence M. Corash, M.D. to Senior Vice President and Chief Medical Officer. Mar 3, 2008 236 Company Inviragen Inc. Peterson, Eric Mar 1, 2008 576 AVI BioPharma Names Dr. Leslie Hudson as Chief Executive Officer. Feb 11, 2008 561 Gilead Announces Departure of Caroline Dorsa. Jan 21, 2008 154 Personnel File. Jan 1, 2008 306 DataLase. Brief article Jan 1, 2007 101 Personnel File. Sep 1, 2006 340 Personnel File. Nov 1, 2005 520